MPii Projects’ Technical Presence at AIDS 2018

July 18, 2018

Three MPii projects showcased their evidence-based work at AIDS 2018 in Amsterdam, from July 21 – 27, 2018. Here’s an overview of what was presented: OPTIONS Pre-conference “Insight to Impact: Driving Demand Creation for HIV Prevention.” Oral Abstract Session “Factors influencing initiation, continuation & discontinuation of oral PrEP at selected facilities in South Africa.” Part… Read more »

Read more >

OPTIONS Completes First Plan 4 PrEP Learning Collaborative

June 27, 2018

In March 2018, OPTIONS completed its first Plan 4 PrEP Learning Collaborative (P4P LC) with six participating countries—Botswana, Mozambique, Namibia, Tanzania, Uganda, and Zambia. Designed to help countries in all stages of oral PrEP rollout—from those countries in early stages of consideration to those are actively planning for rollout—the three main components of the learning… Read more »

Read more >

GEMS Launches Toolkit Focused on HIV Drug Resistance

June 12, 2018

The Global Evaluation of Microbicide Sensitivity (GEMS) project has developed a toolkit focused on HIV drug resistance within PrEP rollout programs. These toolkit materials are designed to help policymakers, health care workers, and laboratory personnel develop and implement drug resistance monitoring programs. New materials will be added, so be sure to visit the GEMS website frequently. PrEP… Read more »

Read more >

MPii shares experiences at ICASA and global meetings

December 20, 2017

At ICASA 2017, OPTIONS presented the poster, “Involving young people in rollout of oral PrEP: The case in Kenya.” In November, the GEMS team presented an oral session on the potential challenges that PrEP implementation may pose to HIV drug resistance emergence at the annual meeting for WHO HIVResNet, a global network advising WHO on… Read more »

Read more >

OPTIONS and WHO co-host ICASA satellite session

December 20, 2017

At ICASA 2017, held 4-9 December in Cote d’Ivoire, OPTIONS and WHO co-hosted a satellite session, titled “Making the case for PrEP for women: What we know and experiences to date.” More than 200 people attended the session, which reviewed current and new evidence about delivering oral PrEP to women, particularly adolescent girls and young… Read more »

Read more >

OPTIONS launches “Providing Oral PrEP” video series of lessons learned from demonstration project in Kenya

December 20, 2017

To foster innovation and problem-solving within oral PrEP delivery, AVAC and LVCT Health, through OPTIONS, created six short documentary videos that offer lessons learned for implementers and policymakers. The “Providing Oral PrEP” videos capture real stories from end users and providers about their experiences with oral PrEP, looking closely at several IPCP demonstration project sites… Read more »

Read more >

MPii presents at three international conferences

September 13, 2017

MPii participated in three international conferences, presenting results from several different areas of work. At the South Africa AIDS Conference in June, OPTIONS presented posters about its iterative process to create information, education, and communication (IEC) materials for the launch of oral PrEP at sex worker sites, as well as efforts to collect additional evidence… Read more »

Read more >

MPii supports Namibia’s efforts for accelerated introduction of HIV prevention products

June 7, 2017

Since June 2016, MPii has worked closely with the USAID/Namibia mission and Namibian Ministry of Health and Social Services to provide technical assistance and support for the country’s HIV prevention programs. Namibia’s National Strategic Framework (NSF) for HIV/AIDS emphasizes a comprehensive package of HIV prevention services. In July 2016, representatives from USAID/HQ and OPTIONS met… Read more »

Read more >

MPii presents at CROI 2017

February 27, 2017

OPTIONS presented two posters at CROI 2017 in February focused on modeling work in Kenya: “Cost-effectiveness of pre-exposure prophylaxis across counties in Western Kenya” and “HIV transmission in generalized, concentrated, and mixed epidemics in Western Kenya.” GEMS also presented the poster, “Does the E138A Mutation in ASPIRE Seroconverters Affect Susceptibility to Dapivirine?”

Read more >

MPii projects share lessons learned with HIV prevention for AGYW

February 27, 2017

Regional representatives of OPTIONS, POWER, CHARISMA, and GEMS shared country experiences and lessons learned from their current MPii work about how to address HIV prevention for adolescent girls and young women (AGYW) in Eastern and Southern Africa during “HIV prevention and sexual and reproductive health and rights for adolescent girls and young women.” Co-convened by… Read more »

Read more >